Orally effective iron chelators for the treatment of iron overload disease: The case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs-Reference-Cited by-同舟云学术

Orally effective iron chelators for the treatment of iron overload disease: The case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs

Published:1998-10 Issue:4 Volume:132 Page:351-352
ISSN:0022-2143
Container-title:Journal of Laboratory and Clinical Medicine
language:en
Short-container-title:Journal of Laboratory and Clinical Medicine

Author:

Richardson Des R.,Ponka Prem

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference8 articles.

1. Iron chelation therapy: the need for orally active drugs;Hoffbrand;J Lab Clin Med,1998

2. Pyridoxal isonicotinoyl hydrazone and its analogs: potential orally effective iron-chelating agents for the treatment of iron overload disease;Richardson;J Lab Clin Med,1998

3. Long-term follow up of body iron in patients with thalassemia major during therapy with the orally active iron chelator deferiprone (LI);Olivieri;Blood,1996

4. Iron-chelation therapy and the treatment of thalassemia;Olivieri;Blood,1997

5. Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients;Hoffbrand;Blood,1998

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Encapsulation and Biological Activity of Hesperetin Derivatives with HP-β-CD;Molecules;2023-09-30

2. Design, Synthesis and Anti-tuberculosis Activity of Hydrazones and N-acylhydrazones Containing Vitamin B6 and Different Heteroaromatic Nucleus;Letters in Drug Design & Discovery;2019-06-27

3. Light-triggered release of photocaged therapeutics - Where are we now?;Journal of Controlled Release;2019-03

4. An experimental and DFT study on free radical scavenging activity of hesperetin Schiff bases;Chemical Physics;2019-01

5. 3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy;Frontiers in Pharmacology;2018-09-07